Bath & Body Works (NYSE:BBWI) Price Target Raised to $22.00 at Deutsche Bank Aktiengesellschaft

Bath & Body Works (NYSE:BBWI) had its target price increased by Deutsche Bank Aktiengesellschaft from $21.00 to $22.00 in a report published on Tuesday morning,MarketScreener reports. Deutsche Bank Aktiengesellschaft currently has a hold rating on the stock.

Other equities analysts also recently issued research reports about the stock. Raymond James Financial reaffirmed a “market perform” rating on shares of Bath & Body Works in a research note on Wednesday, November 12th. Zacks Research raised Bath & Body Works from a “strong sell” rating to a “hold” rating in a research report on Tuesday, January 20th. UBS Group lifted their target price on Bath & Body Works from $21.00 to $22.00 and gave the stock a “neutral” rating in a report on Monday, February 23rd. Jefferies Financial Group initiated coverage on Bath & Body Works in a research note on Wednesday, January 14th. They issued a “hold” rating and a $24.00 price target for the company. Finally, Telsey Advisory Group lifted their price objective on Bath & Body Works from $17.00 to $23.00 and gave the stock a “market perform” rating in a research note on Friday, February 27th. Three investment analysts have rated the stock with a Buy rating and fourteen have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $23.86.

Bath & Body Works Price Performance

Shares of NYSE BBWI opened at $22.43 on Tuesday. The company has a 50 day simple moving average of $22.25 and a 200 day simple moving average of $23.59. Bath & Body Works has a 1 year low of $14.27 and a 1 year high of $35.21. The firm has a market cap of $4.59 billion, a PE ratio of 6.90, a price-to-earnings-growth ratio of 0.97 and a beta of 1.48.

Bath & Body Works Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, March 6th. Investors of record on Friday, February 20th will be given a dividend of $0.20 per share. The ex-dividend date is Friday, February 20th. This represents a $0.80 annualized dividend and a dividend yield of 3.6%. Bath & Body Works’s dividend payout ratio is presently 24.62%.

Hedge Funds Weigh In On Bath & Body Works

Several institutional investors have recently added to or reduced their stakes in BBWI. AQR Capital Management LLC boosted its holdings in shares of Bath & Body Works by 132.5% during the 4th quarter. AQR Capital Management LLC now owns 11,445,928 shares of the company’s stock worth $229,834,000 after buying an additional 6,523,960 shares in the last quarter. American Century Companies Inc. lifted its position in shares of Bath & Body Works by 2,204.1% during the 3rd quarter. American Century Companies Inc. now owns 5,174,370 shares of the company’s stock valued at $133,292,000 after acquiring an additional 4,949,796 shares during the period. Jupiter Asset Management Ltd. boosted its stake in Bath & Body Works by 553.2% during the third quarter. Jupiter Asset Management Ltd. now owns 3,714,499 shares of the company’s stock worth $95,685,000 after acquiring an additional 3,145,797 shares in the last quarter. Norges Bank acquired a new stake in Bath & Body Works in the fourth quarter worth $55,504,000. Finally, Balyasny Asset Management L.P. acquired a new stake in Bath & Body Works in the fourth quarter worth $54,785,000. 95.14% of the stock is owned by institutional investors and hedge funds.

Key Bath & Body Works News

Here are the key news stories impacting Bath & Body Works this week:

• Positive Sentiment: Collaboration and seasonal product momentum could boost spring sales and shopper interest, supporting valuation conversations among investors. Bath & Body Works (BBWI) Valuation Check As PEEPS Collaboration Draws Spring Shopper Interest
• Positive Sentiment: At least one independent outlet shows a modestly higher price target ($23), providing some near-term upside narrative for investors. Price Target Raised to $23
• Neutral Sentiment: Earnings are the immediate catalyst — several previews note this quarter will test Bath & Body Works’ turnaround progress and will likely drive intraday volatility. Bath & Body Works earnings on deck: Turnaround test looms
• Neutral Sentiment: Analyst actions are mixed but modest: Deutsche Bank raised its PT to $22 (hold) and Barclays nudged its PT to $21 (equal weight); these moves are minor and don’t change consensus conviction. Deutsche Bank adjusts PT to $22
• Negative Sentiment: A significant legal overhang: multiple law firms have filed or announced securities class actions and are soliciting lead plaintiffs with March filing deadlines—this raises litigation risk and potential future costs. Portnoy Law Firm Announces Class Action
• Negative Sentiment: Institutional selling: Cooper Creek liquidated a ~5.0M‑share position in Q4, reducing a ~$129M stake — a material block sale that can pressure the stock and reflect waning institutional conviction. This $129 Million Bath & Body Works Stake Got Liquidated

Bath & Body Works Company Profile

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.